Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HAQIMONO a Non-interventional National Multicenter Study, Observing RA Patients Treated With Tocilizumab in Mono-therapy, i.e. Without Combination With DMARD

NCT01669902 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01669902
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01669902 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HAQIMONO a Non-interventional National Multicenter Study, Observing RA Patients Treated With Tocilizumab in Mono-therapy, i.e. Without Combination With DMARD
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
April 30, 2012
Completion date
September 30, 2014
Enrollment
107 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis